Novelix Pharmaceuticals Ltd — Insider Trading, 31-03-2026: Insider Trading / SAST

The company has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in anticipation of the forthcoming financial results for the quarter and half-year. During this period, trading in company securities by these individuals is prohibited. This measure is a standard practice to prevent insider trading and ensure market fairness ahead of material financial disclosures, impacting only specific insiders and not general shareholders.